loading page

Ultrasound studies on Mycoplasma bronchopneumonia
  • +8
  • Clelia Tripaldi,
  • Marella Polito,
  • Onofrio Iacoviello,
  • Vincenzo Basile,
  • Teresa De Bellis,
  • Maria Fortunato,
  • Francesca Laforgia,
  • Mariangela Rubino,
  • Egisto Scalini,
  • Maria Silletti,
  • Ignazio Lofù
Clelia Tripaldi
Hospital of Monopoli

Corresponding Author:[email protected]

Author Profile
Marella Polito
Training Course in General Medicine, Bari Medical Association, Italy
Author Profile
Onofrio Iacoviello
University of Bari
Author Profile
Vincenzo Basile
Hospital of Monopoli
Author Profile
Teresa De Bellis
Hospital of Monopoli
Author Profile
Maria Fortunato
Hospital of Monopoli
Author Profile
Francesca Laforgia
Hospital of Monopoli
Author Profile
Mariangela Rubino
Hospital of Monopoli
Author Profile
Egisto Scalini
Hospital of Monopoli
Author Profile
Maria Silletti
Hospital of Monopoli
Author Profile
Ignazio Lofù
Hospital of Monopoli
Author Profile

Abstract

Abstract Background: Pediatric bronchopneumonia represents a clinical challenge, especially when it comes to the identification of its etiology. Study design: We performed a retrospective study on 100 patients admitted to our pediatric department. Only patients with bronchopneumonic consolidations were selected, discharged with a diagnosis of Community-Acquired Pneumonia (CAP) or bronchopneumonia. The purpose of our study was to identify Mycoplasma pneumonia based on lung ultrasound (LUS) findings. Methodology: At least two lung LUS were performed on each patient: on admission and few days after start of therapy, with some patients undergoing a third ultrasound evaluation approximately one week after discharge. These reports were collected for each patient together with clinical and laboratory data. The study population was divided into two groups: patients who tested positive for Mycoplasma pneumoniae (Myc-CAP) and negative ones (non-Myc-CAP). All patients performed serological test for determination of anti-mycoplasma antibodies, and in doubtful cases also molecular test with PCR on pharyngeal exudate. Results: The results obtained after statistical analysis showed no significant differences in LUS findings between the two groups, that could allow a positive differential diagnosis of Myc-CAP without resorting to laboratory testing. Conclusions: LUS undoubtedly represents a valid and irreplaceable help in the morphological study of pulmonary lesions over the course of disease from the time of admission to follow-up.